NCT02524522

Brief Summary

This study evaluates the influence of alveolar recruitment maneuver, protocolized liberation from respiratory support and monitoring of Integrated Pulmonary Index on the duration of the mechanical ventilation and the number of pulmonary complications in the early postoperative period after cardiac surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2015

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

August 4, 2015

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 14, 2015

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2016

Completed
Last Updated

April 6, 2016

Status Verified

April 1, 2016

Enrollment Period

4 months

First QC Date

August 4, 2015

Last Update Submit

April 5, 2016

Conditions

Keywords

Integrated Pulmonary Indexautomated protocol-driven weaningpulmonary recruitment maneuver

Outcome Measures

Primary Outcomes (1)

  • Duration of postoperative mechanical ventilation

    Participants will be followed for the duration of mechanical ventilation, an expected average of 4 hrs

    24 hrs

Secondary Outcomes (2)

  • Reduced incidence of postoperative respiratory complications

    up to 28 days postoperatively

  • Duration of intensive care unit stay

    72 hours

Study Arms (2)

INTELLiVENT-ASV mode

ACTIVE COMPARATOR

Active comparator: Discontinuation of mechanical ventilation in postoperative period will be provided using automatically driven mode - INTELLiVENT-ASV. In the INTELLiVENT-ASV mode target EtCO2 will be 30-35 mm Hg, target SpO2 - 94-98%, quick wean option - activated.

Device: INTELLiVENT-ASV mode

SIMV mode

ACTIVE COMPARATOR

Active comparator: Discontinuation from mechanical ventilation in postoperative period will be provided using physician driven protocol. The synchronized intermittent mandatory ventilation (SIMV) mode settings will be as follows: PEEP 5 cm of water, FiO2 to achieve SpO2 \> 94 %. Inspiratory pressure will be adjusted to deliver a tidal volume (VT) of 8 mL/kg predicted body weight; pressure support will be 2 cm of water higher. Respiratory rate (RR) will be adjusted to provide EtCO2 of 30-35 mm Hg. Respiratory rate and inspiratory pressure will be decreased gradually every 30 minutes. After decrease of inspiratory pressure to 6 cm of water (8 cm of water in case of BMI \> 30 kg/m2) and respiratory rate to 6/min, the spontaneous breathing trial (SBT) will be started.

Device: SIMV mode

Interventions

Discontinuation with INTELLiVENT-ASV mode: discontinuation from mechanical ventilation in the early postoperative period will be provided by quick-wean option of INTELLiVENT-ASV mode

INTELLiVENT-ASV mode
SIMV modeDEVICE

Discontinuation with SIMV mode: discontinuation with SIMV mode: discontinuation from mechanical ventilation in the early postoperative period will be provided in SIMV mode using physician driven algorithm

SIMV mode

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Informed consent.
  • Elective OPCAB.

You may not qualify if:

  • Participation in any other study.
  • Morbid obesity (BWI \> 40).
  • The risk of pneumothorax after alveolar recruitment due to pulmonary emphysema.
  • Constant atrial fibrillation with pulse rate exceeding 100/min.
  • Inability to breathe easily through the nostrils and thus to gain good quality EtCO2 readings while breathing spontaneously, due to chronic rhinitis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

City hospital # 1 / Northern State Medical University,

Arkhangelsk, 163001, Russia

Location

Related Links

MeSH Terms

Conditions

Pulmonary Atelectasis

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract Diseases

Study Officials

  • Mikhail Y KIrov, MD, PhD

    Northern State Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, head of Anesthesiology dept.

Study Record Dates

First Submitted

August 4, 2015

First Posted

August 14, 2015

Study Start

August 1, 2015

Primary Completion

December 1, 2015

Study Completion

February 1, 2016

Last Updated

April 6, 2016

Record last verified: 2016-04

Data Sharing

IPD Sharing
Will not share

Locations